Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Clinical trial NCT04958785 · TERMINATED
Trial details
- NCT number
- NCT04958785
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2024-10-08
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.